greeksoup/ stock research

Nvidia Corp.

CIK 1045810 · latest 13F filed 14 August 2026 · Read the filing on EDGAR

Nvidia Corp. reported 8 US-listed holdings worth $63.44 billion in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Intel Corp. (47.3%), Space Exploration Techn Corp. Class A Com STK (33.1%) and Coreweave Inc. (7.4%). Against the quarter before, it opened 1 position, added to 0, trimmed 0 and sold out of 0.

Reported holdings$63.44B+245.3% on Q1 2026
Positions8+1 on Q1 2026
The largest ten100.0%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
Where the money is
OpenedHeld
INTC47.3%SPCX33.1%CRWV7.4%COHR4.8%NOK3.5%SNPS3.4%

The 8 largest of its 8 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $432.9 million in 6 positions$433MQ3 24Q4 2024: $304.5 million in 5 positions$305MQ4 24Q1 2025: $1.15 billion in 6 positions$1.15BQ1 25Q2 2025: $4.33 billion in 6 positions$4.33BQ2 25Q3 2025: $3.84 billion in 6 positions$3.84BQ3 25Q4 2025: $13.10 billion in 5 positions$13.1BQ4 25Q1 2026: $18.37 billion in 7 positions$18.4BQ1 26Q2 2026: $63.44 billion in 8 positions$63.4BQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What it did on the quarter

Opened 1Held 7
Opened: 1Held: 7

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 1

  1. Space Exploration Techn Corp. Class A Com STK SPCX$20.98 billion

What it holds

CompanySharesValueOf its bookChange in shares
Intel Corp. INTC214,776,632$29.99 billion47.27%no change
Space Exploration Techn Corp. Class A Com STK SPCX122,764,805$20.98 billion33.06%new
Coreweave Inc. CRWV47,213,353$4.70 billion7.41%no change
Coherent Corp. COHR7,788,161$3.07 billion4.84%no change
Nokia Corporation NOK166,389,351$2.21 billion3.48%no change
Synopsys Inc. SNPS4,821,717$2.15 billion3.39%no change
Yandex N V NBIS1,190,476$328.8 million0.52%no change
Generate Biomedicines Inc. GENB833,325$14.1 million0.02%no change
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before.